Switching from reference adalimumab to biosimilar. Assessment of clinical outcomes in psoriasis

Wiley, International Journal of Dermatology, 3(62), 2022

Journal article published in 2022 by Ricardo Ruiz‐Villaverde

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by